B. Lynne Parshall, Director at CYTOKINETICS INC (CYTK), sold 5,000 shares at $54.22 ($271K) on 2024-07-01, disclosed to the SEC on 2024-07-01.
Scheduled sale ($271k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |